Biotechnology Market

Global Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017

  • Rep Id : TMRGL498
  • Published On : Apr 2013
  • No. of Pages : 115
  • Category : Healthcare

Table of Content
 
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
 
Chapter 2 Executive Summary
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
      3.3.1 Regulatory Support
      3.3.2 Increasing Food Demand 
      3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
      3.4.1 Ethical Issues Associated with Clinical Trials
      3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
      3.5.1 Emergence of Biosimilars
      3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of New Entrants
      3.6.4 Threat from Substitutes
      3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
      3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
      3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
      4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
      4.2.1 Biopharmacy
              4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
      4.2.2 Bioservices
              4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
      4.2.3 Bioagriculture
              4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
      4.2.4 Bioindustrial
              4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
 
Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
      5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
      5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
      5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
      5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
5.5 Nanobiotechnology
      5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
5.6 Chromatography
      5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
5.7 Dna Sequencing Technology
      5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
5.8 Cell Based Assay
      5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
      5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)
 
Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
      6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
      6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
      6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
              6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
              6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
              6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
              6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
6.3 Europe
      6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
      6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
              6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
              6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
              6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
              6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
6.4 Asia Pacific
      6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
      6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
               6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
               6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
               6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
               6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
6.5 Rest Of World
      6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
      6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
              6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
              6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
              6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
              6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)
 
Chapter 7 Company Profile
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Business Strategies
      7.1.4 Swot Analysis
      7.1.5 Recent Developments
7.2 Amgen Inc.
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Business Strategy
      7.2.4 Swot Analysis
      7.2.5 Recent Developments
7.3 Glaxosmithkline
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Business Strategy
      7.3.4 Swot Analysis
      7.3.5 Recent Developments
7.4 Johnson And Johnson
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Business Strategy.
      7.4.4 Swot Analysis
      7.4.5 Recent Developments
7.5 Merck
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Business Strategy
      7.5.4 Swot Analysis
      7.5.5 Recent Developments
7.6 Novartis
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Business Strategy
      7.6.4 Swot Analysis
      7.6.5 Recent Developments
7.7 Novo Nordisk
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Swot Analysis
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Business Strategies.
      7.8.4 Swot Analysis
      7.8.5 Recent Developments
7.9 Roche
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Business Strategies
      7.9.4 Swot Analysis
      7.9.5 Recent Developments
7.10 Sanofi - Aventis
      7.10.1 Company Overview
      7.10.2 Financial Overview
      7.10.3 Business Strategy
      7.10.4 Swot Analysis
      7.10.5 Recent Developments
7.11 Lonza Group Ltd.
      7.11.1 Company Overview
      7.11.2 Financial Overview
      7.11.3 Business Strategy
      7.11.4 Swot Analysis
      7.11.5 Recent Developments
7.12 Biogen Idec Inc
      7.12.1 Company Overview
      7.12.2 Financial Overview
      7.12.3 Business Strategy
      7.12.4 Swot Analysis
      7.12.5 Recent Developments
7.13 Astra Zeneca
      7.13.1 Company Overview
      7.13.2 Financial Overview
      7.13.3 Business Strategy
      7.13.4 Swot Analysis
      7.13.5 Recent Developments
7.14 Genentech
      7.14.1 Company Overview
      7.14.2 Financial Overview
      7.14.3 Business Strategies
      7.14.4 Swot Analysis
      7.14.5 Recent Developments
7.15 Genzyme
      7.15.1 Company Overview
      7.15.2 Financial Overview
      7.15.3 Swot Analysis
      7.15.4 Recent Developments
7.16 Gilead Sciences
      7.16.1 Company Overview
      7.16.2 Financial Overview
      7.16.3 Swot Analysis
      7.16.4 Business Strategies
      7.16.5 Recent Developments
7.17 Celgene
      7.17.1 Company Overview
      7.17.2 Financial Overview
      7.17.3 Business Strategy
      7.17.4 Swot Analysis
      7.17.5 Recent Developments

List of Tables
 
Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

List of Figures 
 
Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

.